Nano-biomaterials: A Site-Targeted Approach to Antidiabetic Drug Delivery

Diabetes has become a global health crisis, marked by a significant increase in prevalence. This chapter delves into the distinct characteristics, prevalence, and complications of Type I and Type II diabetes, emphasizing the urgency of addressing this escalating epidemic. Current strategies to combat diabetes include public health campaigns, lifestyle interventions, early diagnosis, and improved healthcare access. The economic impact underscores the need for innovative solutions, and one promising avenue is the use of nano-biomaterials for targeted antidiabetic drug delivery. Nano-biomaterials, operating at the nanoscale, offer precision and effectiveness in drug delivery, potentially revolutionizing diabetes therapies. The chapter advocates for preventative measures, understanding economic implications, and exploring cutting-edge solutions like nano-biomaterials for targeted drug delivery to address diabetes as a global health crisis. Additionally, it delves into nanocarrier strategies for enhanced delivery of antidiabetic agents, exploring nanoparticulate approaches for improved therapy in hyperglycemic conditions. Nano-formulations, such as nanoparticles and nanostructured lipid carriers, offer advantages like reduced dosage, rapid onset of action, sustained release, targeted delivery, and improved bioavailability. Incorporating polymers, both synthetic and natural, enhances the design flexibility and biocompatibility of these delivery systems, showing promise in delivering antidiabetic phytocompounds. The comprehensive discussion on the utilization of nano-biomaterials and nanocarrier strategies sheds light on innovative approaches to diabetes management, holding the potential to offer more efficient, patient-friendly, and economically viable solutions amidst the diabetes pandemic. In conclusion, this chapter emphasizes the importance of a multidimensional approach, involving public health initiatives, socioeconomic considerations, and cutting-edge technologies to effectively address the challenges posed by diabetes globally.